Literature DB >> 7749856

LDL physical and chemical properties in familial combined hyperlipidemia.

J E Hokanson1, R M Krauss, J J Albers, M A Austin, J D Brunzell.   

Abstract

Familial combined hyperlipidemia (FCHL) is characterized by elevations of triglyceride and/or cholesterol within families and an elevation in apoB. Although small dense LDL has been consistently associated with hypertriglyceridemia, small dense LDL persists despite reductions in triglyceride after treatment with gemfibrozil in FCHL. The current study evaluated potential differences in the distribution and chemical composition of LDL species in patients with FCHL and normolipidemic control subjects. LDL from FCHL patients was characterized by a relative abundance of a discrete LDL species with a mean peak analytic ultracentrifuge flotation rate (S0f) of 4.7 +/- 0.5 (SEM), a density of 1.041 +/- 0.001 g/mL, and a particle diameter of 250 +/- 1 A as assessed by gradient gel electrophoresis. The major LDL species in the control subjects had a higher mean S0f rate (6.3 +/- 0.4), was more buoyant (density, 1.037 +/- 0.001 g/mL), and was larger (diameter, 262 +/- 2 A). In addition, in a series of six LDL fractions separated by equilibrium density gradient ultracentrifugation, particle diameters were significantly smaller in all fractions from FCHL patients compared with those from control subjects. LDL particles from patients contained less free cholesterol, cholesteryl ester, and phospholipid than LDL from control subjects. The amount of triglyceride per LDL particle, however, did not differ between FCHL patients and control subjects. Differences in flotation rate and mass of the major LDL species between patients and control subjects could not be fully accounted for by differences in plasma triglyceride levels. Thus, LDL particles from FCHL patients are smaller and more dense with less cholesterol and phospholipid. Many of these differences appear to be independent of plasma triglyceride.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7749856     DOI: 10.1161/01.atv.15.4.452

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  9 in total

1.  Serum lipid profiles, the prevalence of dyslipidemia and the risk factors in two isolated Chinese minorities.

Authors:  Pei-Juan Liao; Rui-Bin Xie; Rui-Xing Yin; Dai-Xun Wei; Jian Huang; Feng Huang; Hui Li; Wei-Xiong Lin; Jin-Zhen Wu; Shang-Ling Pan
Journal:  Int J Clin Exp Med       Date:  2015-10-15

2.  Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia.

Authors:  S J Bredie; L A Kiemeney; A F de Haan; P N Demacker; A F Stalenhoef
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

3.  Endothelial lipase mediates HDL levels in normal and hyperlipidemic rabbits.

Authors:  Jifeng Zhang; Ying Yu; Kae Nakamura; Tomonari Koike; Ahmed Bilal Waqar; Xiaowei Zhang; Enqi Liu; Kazutoshi Nishijima; Shuji Kitajima; Masashi Shiomi; Zhongxia Qi; Jingwei Yu; Mark J Graham; Rosanne M Crooke; Tatsuro Ishida; Ken-Ichi Hirata; Eva Hurt-Camejo; Y Eugene Chen; Jianglin Fan
Journal:  J Atheroscler Thromb       Date:  2012-01-12       Impact factor: 4.928

4.  Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway.

Authors:  Thomas M van Himbergen; Seiko Otokozawa; Nirupa R Matthan; Ernst J Schaefer; Aaron Buchsbaum; Masumi Ai; Lambertus J H van Tits; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-15       Impact factor: 8.311

5.  A common genetic mechanism determines plasma apolipoprotein B levels and dense LDL subfraction distribution in familial combined hyperlipidemia.

Authors:  S H Juo; S J Bredie; L A Kiemeney; P N Demacker; A F Stalenhoef
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

6.  Molecular structure of low density lipoprotein: current status and future challenges.

Authors:  Ruth Prassl; Peter Laggner
Journal:  Eur Biophys J       Date:  2008-09-17       Impact factor: 1.733

7.  Hypertriglyceridemia is a major factor associated with elevated levels of small dense LDL cholesterol in patients with metabolic syndrome.

Authors:  Yonggeun Cho; Sang Guk Lee; Sun Ha Jee; Jeong Ho Kim
Journal:  Ann Lab Med       Date:  2015-11       Impact factor: 3.464

8.  Prevalence and associated factors of uncontrolled hyperlipidemia among Thai patients with diabetes and clinical atherosclerotic cardiovascular diseases: a cross-sectional study.

Authors:  Teeraboon Lertwanichwattana; Ram Rangsin; Boonsub Sakboonyarat
Journal:  BMC Res Notes       Date:  2021-03-25

Review 9.  Dyslipidemia in obesity: mechanisms and potential targets.

Authors:  Boudewijn Klop; Jan Willem F Elte; Manuel Castro Cabezas
Journal:  Nutrients       Date:  2013-04-12       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.